Startups

Ancora Biotech logo

Ancora Biotech

Palo Alto, California

Bispecifics for B-cell cancers, metabolic disease, and HBV. Founded 2021. Palo Alto. Later acquired by AstraZeneca.

Founded 2021

Team

No team members on record yet.

Investments

$60M2022-06-09Lightspeed
$60MUnknown dateLightspeed, SR One